United States · FDA National Drug Code directory
Oxaliplatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-358_3fee20f4-5fee-8b4e-e063-6294a90a1a0a
- Product NDC
- 31722-358
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Oxaliplatin
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250127
- Source listing expiry
- 20261231
Source-listed ingredients
- OXALIPLATIN — 100 mg/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-358-20) / 20 mL in 1 VIAL, SINGLE-DOSE · 31722-358-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →